NFATC1 isoform editing via RNP-mediated CRISPR/Cas9 in human primary T cells and its \(in\) \(vitro\) effects
Bee, Svenja · Online Publication Service of Würzburg University (Würzburg University) · 2025
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Online Publication Service of Würzburg University (Würzburg University) · University of Würzburg · dissertation · 2025
Abstract
Allo-HCT is a valuable and well-established treatment option for patients with hematologic malignancies, however occurring GvHD limits its prospects of success, resembling a severe side effect and significantly increasing morbidity and mortality. While there are different therapy options, they still lack in efficiency, are likely to cause (severe) side-effects themselves, and curtail the desired GvL effect. Hence, better treatment options, especially for steroid-refractory GvHD are required to improve allo-HCT.
Selective inhibition of NFAT transcription factors has shown to support Treg expansion and weaken TEFF responses, therefore ameliorating GvHD towards lasting tolerance in a mouse model. Indeed, instead of ablating NFATc1 expression, hindering merely its SUMOylation enabled generation of more tolerogenic T cells causing less GvHD. This motivated us to transfer this concept to human T cells, by generating INDEL mutations in the long isoform specific DNA parts, harboring the SUMOylation sites. In this study, we successfully developed a protocol for isoform-specific gene editing via RNP-mediated CRISPR/Cas9 in unstimulated human T cells, specifically creating NFATC1ΔBC T cells.
We were able to achieve a high knockout efficiency, while maintaining good cell viability and proliferation capacities. After the RNP-nucleofection, we cultivated the cells in vitro for three more days. Then, we examined effects regarding T cell subpopulations, surface marker expression, cytokine expression and presence of certain transcription factors. We found that NFATC1deltaBC T cells provoked an enhanced Treg frequency, in line with an enhanced IL-10 secretion. Additionally, the memory T cell population shifted from TEM to more TCM, as well as towards more TSCM at the expense of naïve T cells.
Although they still expressed pro-inflammatory cytokines to a similar degree and expressed more CD40L on their surface, overall we see striking parallels to the behavior of murine Nfatc1deltaSUMO and Nfatc1deltaBC T cells. Hereby, we deduct that NFATC1ΔBC expressing human T cells appear to behave more tolerogenic, which should be tested in a more complex in vitro study by co-culturing them with 3D-organoids in order to understand the interaction with the extracellular environment and tendency to infiltrate tissue and cause damage.
Open the resolved locator · 10.25972/opus-40407
Metadata licence: OpenAlex metadata (CC0)